Published in Lancet Glob Health on August 30, 2016
Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence | NCT04448145
Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys. Nat Microbiol (2017) 0.83
Rebuilding transformation strategies in post-Ebola epidemics in Africa. Infect Dis Poverty (2017) 0.77
Screening of genital fluid for Ebola virus. Lancet Glob Health (2017) 0.75
Ebola virus lingers longer than scientists thought. Nature (2016) 0.75
Ebola Virus RNA in Semen from an HIV-Positive Survivor of Ebola. Emerg Infect Dis (2017) 0.75
Chemically Modified Human Serum Albumin Potently Blocks Entry of Ebola Pseudoviruses and Viruslike Particles. Antimicrob Agents Chemother (2017) 0.75
Sex practices and awareness of Ebola virus disease among male survivors and their partners in Guinea. BMJ Glob Health (2017) 0.75
Reduced evolutionary rate in reemerged Ebola virus transmission chains. Sci Adv (2016) 1.12
Bolstering Community Cooperation in Ebola Resurgence Protocols: Combining Field Blood Draw and Point-of-Care Diagnosis. PLoS Med (2017) 0.83
Mortality, Morbidity and Health-Seeking Behaviour during the Ebola Epidemic 2014-2015 in Monrovia Results from a Mobile Phone Survey. PLoS Negl Trop Dis (2016) 0.75
Improving water, sanitation and hygiene in health-care facilities, Liberia. Bull World Health Organ (2017) 0.75
Evidence-based guidelines for supportive care of patients with Ebola virus disease. Lancet (2017) 0.75
Screening of genital fluid for Ebola virus - Authors' reply. Lancet Glob Health (2017) 0.75
Analysis of patient data from laboratories during the Ebola virus disease outbreak in Liberia, April 2014 to March 2015. PLoS Negl Trop Dis (2017) 0.75
Pregnancy outcomes in Liberian women who conceived after recovery from Ebola virus disease. Lancet Glob Health (2016) 0.75
The development, use, and impact of a global laboratory database during the 2014 Ebola outbreak in West Africa. J Infect Dis (2017) 0.75